BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6288953)

  • 1. Influence of sulpiride-induced hyperprolactinemia on baboon menstrual cycles: a longitudinal study.
    Aso T; Matsuoka M; Su J; Horie K; Taii S; Motohashi T; Nishimura T
    J Med Primatol; 1982; 11(1):20-34. PubMed ID: 6288953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exogenous conjugated estrogen on plasma gonadotropins and ovarian steroids during the menstrual cycle.
    Abraham GE; Chakmakjian ZH; Buster JE; Marshall JR
    Obstet Gynecol; 1974 May; 43(5):676-84. PubMed ID: 4362727
    [No Abstract]   [Full Text] [Related]  

  • 3. Alteration of feedback mechanism of estrogen on gonadotropin by sulpiride-induced hyperprolactinemia.
    L'Hermite M; Delogne-Desnoeck J; Michaux-Duchene A; Robyn C
    J Clin Endocrinol Metab; 1978 Nov; 47(5):1132-6. PubMed ID: 233689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baboon as an animal model for research of human reproduction.
    Horie K
    Jpn J Med Sci Biol; 1983 Aug; 36(4):244-8. PubMed ID: 6317925
    [No Abstract]   [Full Text] [Related]  

  • 5. [Variation of serum gonadotropins and progesterone during hyperprolactinemia induced by sulpiride (Dogmatil) during the luteal phasis of the menstrual cycle].
    Delvoye P; Taubert HD; Jurgensen O; L'Hermite M; Delogne J; Robyn C
    C R Acad Hebd Seances Acad Sci D; 1974 Oct; 279(17):1463-6. PubMed ID: 4219166
    [No Abstract]   [Full Text] [Related]  

  • 6. Modulation of ovarian LH receptor and serum hormone levels in rats with hyperprolactinemia induced by administration of ovine prolactin or sulpiride.
    Ota H; Wakizaka A; Fukushima M
    Tohoku J Exp Med; 1986 Feb; 148(2):213-27. PubMed ID: 3008378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The change of hypothalamic-pituitary-ovarian function during peripubertal period in female baboons (author's transl)].
    Su JH
    Nihon Naibunpi Gakkai Zasshi; 1981 May; 57(5):779-94. PubMed ID: 6793412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary and ovarian response to luteinizing hormone releasing factor in normal and sulpiride-induced hyperprolactinemic women.
    Yagi S; Nakano R
    Obstet Gynecol; 1982 Nov; 60(5):571-6. PubMed ID: 6815597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic sulpiride-induced hyperprolactinemia on menstrual cycles of normal women.
    Oseko F; Morikawa K; Motohashi T; Aso T
    Obstet Gynecol; 1988 Aug; 72(2):267-71. PubMed ID: 3134632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired steroidogenic function of corpora lutea from hyperprolactinemic baboons induced by sulpiride.
    Horie K; Ban C; Taii S; Mori T; Aso T
    Endocrinol Jpn; 1986 Apr; 33(2):211-4. PubMed ID: 3093203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired LH-RH release by estrogen in women with sulpiride-induced hyperprolactinemia.
    Aono T; Miyake A; Koike K; Tasaka K; Kurachi K
    Endocrinol Jpn; 1984 Oct; 31(5):571-5. PubMed ID: 6440785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A clinical study on the characteristics of galactorrhea-amenorrhea (especially of drug-induced galactorrhea-amenorrhea].
    Onda H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1851-60. PubMed ID: 6438254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effects of sulpiride on plasma LH, FSH, and progesterone in women during the reproductive years. Role of hyperprolactinism in ovulation disorders].
    Buvat J; Thomas K; Buvat-Herbaut M; Havard J; Blacker C; Gasnaut JP; Linquette M; Ferin J
    J Gynecol Obstet Biol Reprod (Paris); 1978 Jan; 7(1):5-18. PubMed ID: 641315
    [No Abstract]   [Full Text] [Related]  

  • 15. Puberty in girls: correlation of serum levels of gonadotropins, prolactin, androgens, estrogens, and progestins with physical changes.
    Lee PA; Xenakis T; Winer J; Matsenbaugh S
    J Clin Endocrinol Metab; 1976 Oct; 43(4):775-84. PubMed ID: 135768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinemia-induced precocious puberty: studies on the mechanism(s) by which prolactin enhances ovarian progesterone responsiveness to gonadotropins in prepubertal rats.
    Advis JP; Richards JS; Ojeda SR
    Endocrinology; 1981 Apr; 108(4):1333-42. PubMed ID: 6781872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinemia in cases of infertility and amenorrhea.
    Furuhjelm M; Rydner T; Carlström K
    Acta Obstet Gynecol Scand; 1980; 59(2):137-41. PubMed ID: 6773290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ovulation by progestin analogs (agonists vs antagonists): preliminary evidence for different sites and mechanisms of actions.
    Heikinheimo O; Gordon K; Williams RF; Hodgen GD
    Contraception; 1996 Jan; 53(1):55-64. PubMed ID: 8631191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma testosterone and prolactin in the menstrual cycle.
    Epstein MT; McNeilly AS; Murray MA; Hockaday TD
    Clin Endocrinol (Oxf); 1975 Sep; 4(5):531-5. PubMed ID: 1175313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormonal effects of the 300 microgram norethisterone (NET) minipill. 3. Comparison of the short-term (2nd month) and medium-term (6th month) effects in 21 subjects.
    Landgren BM; Lager S; Diczfalusy E
    Contraception; 1981 Mar; 23(3):269-99. PubMed ID: 6786830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.